Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Black-Box Warning for Plavix. Confusion May Follow
WSJ Online
Monday, March 15, 2010 - 11:53am
tags:
black box, warnings, FDA, Plavix, blood thinners, Sanofi, Bristol-Myers Squibb
Inspire Pharmaceuticals' eye drug Azasite fails to meet key goals in midstage studies
Yahoo/AP
Monday, March 15, 2010 - 11:50am
tags:
Inspire, Azasite
Amylin, Alkermes Gain as FDA Doesn’t Need More Byetta Data
Bloomberg
Monday, March 15, 2010 - 11:49am
tags:
Amylin, Alkermes, FDA, diabetes, Byetta
Boston Scientific Plunges on Defibrillator Sales Halt
Bloomberg
Monday, March 15, 2010 - 11:48am
tags:
Boston Scientific, defibrillators
[video]A Two-ETF Strategy for Biotech
TheStreet.com
Monday, March 15, 2010 - 11:42am
tags:
biotech, ETFs
Industry News Bytes: Delcath, Amylin and Access Pharma
Seeking Alpha
Monday, March 15, 2010 - 11:40am
tags:
Delcath, Access Pharmaceuticals, Amylin, Eli Lilly, Alkermes, Eisai
Studies: Intense treatment doesn't help diabetics
Yahoo/AP
Monday, March 15, 2010 - 10:15am
tags:
diabetes, statins, Abbott Laboratories, Lipitor, Zocor
Abbott's TriCor Fails To Beat A Sugar Pill
Forbes
Monday, March 15, 2010 - 10:14am
tags:
Abbott Laboratories, TriCor, hypertriglyceridemia
Aveo Pharmaceutical shares drop in trading debut
BusinessWeek
Saturday, March 13, 2010 - 11:13am
tags:
Aveo Pharmaceutical
US FDA accepts Abbott's six-month 45-mg formulation of Lupron sNDA for review
Pharmabiz
Saturday, March 13, 2010 - 11:07am
tags:
Abbott Laboratories, Lupron, prostate cancer
TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
Pipeline Review
Saturday, March 13, 2010 - 11:03am
tags:
TaiGen, Nemonoxacin, diabetic infection
EnteroMedics retools, refocuses to win FDA approval
Med City News
Saturday, March 13, 2010 - 10:55am
tags:
EnteroMedics, obesity, Maestro
Ranbaxy eyes 80% rise in income by end of 2012
Sify, India
Saturday, March 13, 2010 - 10:52am
tags:
Ranbaxy, Daiichi Sankyo
Merck's New Cholesterol Pill Gets A Boost
Investor's Business Daily
Saturday, March 13, 2010 - 10:38am
tags:
Merck, Vytorin
Pfizer's 3 Points of Failure
Motley Fool
Saturday, March 13, 2010 - 10:34am
tags:
Pfizer, Sutent, dimebon, figitumumab
Analyst: Merck's Vytorin sales will keep dropping
Yahoo/AP
Saturday, March 13, 2010 - 10:33am
tags:
Merck, Vytorin
Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information
Yahoo/BusinessWire
Saturday, March 13, 2010 - 10:30am
tags:
Sanofi, Bristol-Myers Squibb, Plavix
Cancer Drugs May Not Cure Pfizer
Forbes
Saturday, March 13, 2010 - 10:28am
tags:
Pfizer, Sutent, figitumumab, Avastin
Halozyme narrows 4Q loss due to Hylenex payment
Yahoo/AP
Saturday, March 13, 2010 - 10:25am
tags:
Halozyme, Hylenex, Roche
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Cell Therapeutics, Inc.
Yahoo/MarketWire
Saturday, March 13, 2010 - 10:24am
tags:
Cell Therapeutics, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.